- Home
- HOTH vs MGIH Comparison
HOTH vs MGIH Comparison
Compare HOTH & MGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- MGIH
- Stock Information
- Founded
- HOTH 2017
- MGIH 1978
- Country
- HOTH United States
- MGIH Hong Kong
- Employees
- HOTH N/A
- MGIH N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- MGIH Publishing
- Sector
- HOTH Health Care
- MGIH Consumer Discretionary
- Exchange
- HOTH Nasdaq
- MGIH Nasdaq
- Market Cap
- HOTH 15.6M
- MGIH 18.0M
- IPO Year
- HOTH 2019
- MGIH 2023
- Fundamental
- Price
- HOTH $1.31
- MGIH $1.52
- Analyst Decision
- HOTH Strong Buy
- MGIH
- Analyst Count
- HOTH 3
- MGIH 0
- Target Price
- HOTH $4.00
- MGIH N/A
- AVG Volume (30 Days)
- HOTH 426.2K
- MGIH 19.9K
- Earning Date
- HOTH 05-12-2025
- MGIH 08-12-2025
- Dividend Yield
- HOTH N/A
- MGIH N/A
- EPS Growth
- HOTH N/A
- MGIH N/A
- EPS
- HOTH N/A
- MGIH N/A
- Revenue
- HOTH N/A
- MGIH $28,866,993.00
- Revenue This Year
- HOTH N/A
- MGIH N/A
- Revenue Next Year
- HOTH N/A
- MGIH N/A
- P/E Ratio
- HOTH N/A
- MGIH N/A
- Revenue Growth
- HOTH N/A
- MGIH N/A
- 52 Week Low
- HOTH $0.58
- MGIH $1.32
- 52 Week High
- HOTH $3.80
- MGIH $6.83
- Technical
- Relative Strength Index (RSI)
- HOTH 51.27
- MGIH 39.75
- Support Level
- HOTH $1.21
- MGIH $1.61
- Resistance Level
- HOTH $1.41
- MGIH $1.70
- Average True Range (ATR)
- HOTH 0.10
- MGIH 0.06
- MACD
- HOTH -0.01
- MGIH -0.01
- Stochastic Oscillator
- HOTH 41.30
- MGIH 0.00
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
About MGIH Millennium Group International Holdings Limited
Millennium Group International Holdings Ltd is a paper-based packaging solutions supplier. It offers paper-based inner and outer packaging products which can be broadly categorized into packaging products, Packaging products supply chain management solutions and corrugated products.